Table 3.

DAA medication effect on rCBF (Model 2: rCBF ~ medication status + PC1)

ROI	t-statistic (DF=25)	95 % CI	coefficient	P-valuea
Total gray matter	1.627	[−0.572, 4.872]	2.150	0.116
ACC	0.516	[−3.772, 6.291]	1.260	0.611
MPFC	1.714	[−0.539, 5.879]	2.670	0.099
DLPFC	2.742	[1.007, 7.087]	4.047	0.011b
VLPFC	2.017	[−0.061, 5.806]	2.872	0.055
SMA-p	1.217	[−2.018, 7.842]	2.912	0.235
Pre-SMA	2.155	[0.165, 7.252]	3.709	0.041
M1	1.155	[−1.498, 5.320]	1.911	0.259

^aUncorrected P-value

^bSignificant P-value at FDR = 0.1

DF = Degrees of freedom

Positive coefficients represent higher rCBF in the On-DAA condition.